Close Menu

NEW YORK (GenomeWeb) – Australian diagnostics firm SpeeDx announced today that it has incorporated a US-based subsidiary as it plans for the US launch of its ResistancePlus MG assay for the detection of antibiotic-resistant strains of Mycoplasma genitalium.

The subsidiary is expected to be located in Austin, Texas, a company spokesperson said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.